Atlas Trials

Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia

Clinical trial NCT00726232 · TERMINATED

Trial details

NCT number
NCT00726232
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloproliferative Neoplasm (MPN)
Start date
2008-08-20
Primary completion
2010-06-20
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.